Objectives Corticosteroid treatment of paediatric leukaemia patients can lead to osteonecrosis (ON). We determined whether bone marrow oedema (BME) is an early sign of progressive ON and eventual bone collapse. Methods In a retrospective study, two radiologists reviewed MR imaging characteristics of 47 early stage epiphyseal ON in 15 paediatric and adolescent leukaemia patients. Associations between BME on initial imaging studies and subchondral fracture, disease progression and bone collapse were assessed by Cochran-Mantel-Haenszel tests. Differences in time to progression and bone collapse between lesions with and without oedema were assessed by log rank tests. Results Forty-seven occurrences of ON were located in weight bearing joints, with 77% occurring in the femur. Seventeen lesions progressed to collapse, two lesions worsened without collapse, and 28 remained stable or improved. BME was significantly associated with subchondral fracture (p = 0.0014), disease progression (p = 0.0015), and bone collapse (p < 0.001), with a sensitivity and specificity of 94% and 77%, respectively, for bone collapse. Time to progression for ON with oedema was 2.7 years (95% CI: 1.7-3.4); while the majority of no-oedema ON were stable (p = 0.0011). Conclusions BME is an early sign of progressive ON and eventual bone collapse in paediatric and adolescent leukaemia patients. Key points • Bone marrow oedema in corticosteroid-induced osteonecrosis predicts progression to bone collapse.
Introduction
Osteonecrosis (ON) is a devastating complication of paediatric cancer therapy with high-dose corticosteroids, affecting 15-47% of leukaemia and lymphoma patients [1] [2] [3] [4] and progressing to irreversible bone collapse in up to 22% of patients with clinical risk factors [5] . Unfortunately, jointpreserving interventions are only effective as a preventative measure, when performed prior to actual bone collapse [6, 7] . However, since 60-80% of early stage ON remain stable or even resolve [1] [2] [3] 8] , patients often wait with hopes of spontaneous resolution. While this strategy is suitable for those patients whose lesions resolve, it unfortunately could miss the critical window of opportunity to prevent collapse of progressive lesions. When patients with progressive lesions finally present with major morbidities such as severe pain and limited ambulation, rescue interventions such as surgical decompression is often too late to save the affected joint [1] [2] [3] 8] . This leads to devastating outcomes for those with progressive disease, such as need for total joint replacement. Corticosteroid-induced ON is a multifactorial process ( Fig. 1) , which involves corticosteroid-induced ischaemia and direct induction of marrow cell death through corticosteroid receptor-mediated apoptosis induction [9, 10] . While there are known risk factors for the development of ON in paediatric leukaemia patients, such as dose, type and route of corticosteroid administration, as well as older age, pain, and articular surface involvement [5] , little is known about biomarkers that could predict unfavourable outcomes for a given lesion [11] . This makes it difficult to select lesions that may benefit from preventive interventions rather than a Bwait and watch^ap-proach. A recent study proposed an imaging-based classification of ON in cancer patients, but the prognostic value of specific imaging findings in this classification has not been validated so far [12] . Defining specific imaging biomarkers that can predict impeding bone collapse would substantially improve our ability to offer patients curative interventions before irreversible morbidities occur which require total joint replacement.
It was described in adult patients with symptomatic avascular necrosis of the femoral head that the presence of bone marrow oedema (BME) on magnetic resonance imaging (MRI) correlated with the presence of microfractures or early subchondral fractures on histopathology [13] . Based on these reports, the purpose of our study was to determine whether a BME would be an early sign of progressive ON and eventual bone collapse in paediatric and adolescent leukaemia patients. If confirmed, this new imaging biomarker could be used to stratify high-risk patients to joint-preserving interventions.
Materials and methods

Patient population
This retrospective study was approved by the institutional review board (IRB) at our institution. Informed consent was waived because of the non-invasive and retrospective nature of our analyses and the inability or difficulty to locate most of the patients who had completed their treatment. We identified MRI studies in our hospital from July 2003 until February 2016 of paediatric and adolescent patients with leukaemia who fulfilled the following inclusion criteria: (1) age less than 21 years, (2) diagnosis of leukaemia, (3) treatment with high dose corticosteroids (>6000 mg prednisolone equivalent/m 2 ), and (4) initial MRI with findings consistent with osteonecrosis (in any epiphysis). ON was defined as a focal lesion in the proximal/distal epiphysis of the femur or tibia, surrounded by a characteristic serpentine low signal line. Optional MRI findings that confirmed the diagnosis of ON were a characteristic double line on T2-weighted images (inner hyperintense granulation tissue and outer hypointense fibrosis/sclerosis) and fatty centre. Patients were excluded if: (1) there were metaphyseal or diaphyseal ON only (no epiphyseal involvement), (2) lesions were located in non-weight bearing joints, (3) initial MRI already showing advanced ON with bone collapse, or (4) lack of follow-up imaging. We included nine girls (mean age: 13.5 +/-3.0 years; range: 10-18) and six boys (mean age: 16.8 +/-2.5 years; range: 14-21). Patients received their baseline MRI due to clinical symptoms such as joint pain.
Osteonecrosis assessment
Baseline MRIs were performed on a 3 Tesla (T) MRI scanner (Discovery 750, GE Healthcare, Milwaukee, WI, USA) (n = 11 patients) or a 1.5 T MRI scanner (Optima 450w or Signa Excite, GE Healthcare) (n = 4 patients). A personalised approach was used to ensure minimal scan time and to image the specific joint regions. Repetition times (TRs) and echo times (TEs) were adjusted to ensure an adequate signal-tonoise ratio for all patients. At least two anatomical orientations were acquired, using the following sequences: T1-weighted sequences (TR = 366 -1323 ms, TE = 8 -35 ms, flip angle (α) = 90°-142°, slice thickness (SL) = 2.5 -5 mm); T2 fat saturated (fs) fast spin echo (FSE) sequences (TR/TE/α = 3000 -7500/49 -105/90 -142, SL = 2.5 -6 mm, echo train length = 6 -8); proton density (PD) fs sequences (TR/TE/α = 2952 -4906/15 -35/15 -142, SL = 2.5 -4 mm); and short tau inversion recovery (STIR) sequences (TR/TE/α = 3400 -5400/27 -51/90, SL = 2.5 -5 mm, inversion time = 149 -168 ms).
Follow-up imaging to monitor outcome included MRI (n = 16 in 10 patients) and X-rays (n = 22 in 15 patients) after the baseline study (mean 19 +/-15 months).
Two paediatric radiologists (Heike E. Daldrup-Link, Shanshan Bao) with 13 and 6 years of experience evaluated baseline MRIs and follow-up imaging studies in consensus, according to the following criteria: (i) presence or absence of BME, meaning ill-defined T1 hypointense and T2 hyperintense signal in or around the ON lesion. (ii) presence or absence of a subchondral fracture, (iii) size of ON (<15%, 15-30%, or >30% joint surface involved) [14] , and (iv) severity of the ON lesion from Stage 1 to 4, based on a modified version of the Association Research Circulation Osseous (ARCO) guidelines [14] . Follow-up MR imaging studies and radiographs were staged as described above and evaluated for presence or absence of disease progression, defined as higher ARCO stage compared to the baseline scan, and presence or absence of bone collapse.
Statistical analyses
The presence or absence of BME was displayed in contingency tables against presence or absence of a subchondral fracture and against outcomes of presence or absence of bone collapse. Associations between presence of BME on initial imaging studies and subchondral fracture, disease progression (vs. stability/improvement) and eventual bone collapse were assessed by Cochran-Mantel-Haenszel tests stratified on patient, with calculation of (unadjusted) sensitivity and specificity. Differences in time to progression and time to bone collapse (both from treatment initiation for leukaemia) between lesions with and without oedema were assessed by log rank tests, stratified by patient. All statistical analyses were done with Stata Release 14.1 (StataCorp LP, College Station, TX, USA). A p-value <0.05 was considered to indicate significant differences for all analyses.
Results
According to the inclusion criteria, we identified 73 ON lesions in 23 paediatric and adolescent leukaemia patients who underwent high dose corticosteroid therapy. Of these, 26 lesions were excluded from the analysis because they were not located in the epiphysis (n = 18), or already demonstrated joint surface impression or collapse at the time of diagnosis (n = 4), or were located in non-weight bearing joints (n = 4). We focused more detailed statistical analyses on 47 lesions in 15 patients that demonstrated early stage, pre-collapse epiphyseal ON in weight bearing joints, which would be considered at risk for collapse and could be referred to joint-preserving interventions, such as decompression surgery. These patients ranged in age from 10 to 20 years (mean age 14.8 years +/-3.1 years).
Time from initiation of treatment for leukaemia to initial imaging ranged from 0.3 to 6.6 years (median = 1.1). Lesion size at baseline encompassed less than 15% of the joint surface (n = 4), 15-30% (n = 11), or more than 30% of the joint surface (n = 32). Not surprisingly, larger lesions showed a statistically significant higher frequency of BME than smaller lesions (p = 0.036; Table 1 ). Twenty-three lesions demonstrated an associated BME at the time of diagnosis, while 24 lesions showed no signs of BME. On follow-up imaging scans, 30 lesions remained stable or improved (Figs. 2 and 3) , and 17 lesions worsened or collapsed (Fig. 4) .
Three-quarters (36/47) of the epiphyseal lesions were located in the femur (Supplementary Table 1 ) with a marginal trend for more lesions in the femur than tibia (p = 0.034 by one-sided Fisher's exact test). Almost all cases of bone marrow oedema (21/23), all cases of subchondral fracture (16/16) , and all cases of bone collapse (17/17) were in the femur rather than the tibia. Interestingly, of 11 lesions in the proximal tibia analysed in this study, none progressed to collapse, even though two had BME on initial imaging.
There was a significant association between presence of BME and subchondral fracture (p = 0.0014; Table 2 ). Time to progression and time to bone collapse for patients with oedema was 2.7 years (95% CI: 1.7-3.4); when fewer than half of the no-oedema patients had progressed (p = 0.0011; Fig. 5a/b ). There was a significant association between presence of oedema on imaging and eventual disease progression (unadjusted for time at risk; p = 0.0015; Table 3 ) and bone collapse (p < 0.001; Table 4 ). Overall, the presence of BME had a sensitivity and specificity of 94% and 77%, respectively, for eventual bone collapse.
There was also a significant association between presence of a subchondral fracture on imaging and eventual bone collapse (unadjusted for time at risk, Table 5 ). Time to progression for patients with subchondral fracture was 2.6 years (95% CI: 1.7-2.7) years; when fewer than half the no-fracture patients had progressed (p < 0.001; Fig. 6 ).
Discussion
Our results demonstrate that the presence of BME indicates progressive ON and eventual bone collapse in paediatric and adolescent leukaemia patients who received high dose corticosteroid therapy. In addition, the lack of BME on initial imaging is strongly correlated with stability or improvement of ON. Therefore, the presence or absence of BME on MRI could be used to stratify patients with ON to either jointpreserving interventions or a Bwait and watch^approach.
There are numerous preclinical and clinical imaging investigations that demonstrate the effects of corticosteroids on bone marrow [9, [15] [16] [17] . In addition to indirect effects from induction of ischaemia, corticosteroids have direct effects on marrow cells through corticosteroid receptor-mediated apoptosis induction [9] . Death of mesenchymal stromal cells (MSCs), osteoblasts, and osteoclasts leads to decreased bone turnover and decreased trabecular thickness. Furthermore, corticosteroids enhance MSC differentiation into adipocytes and inhibit MSC differentiation into osteocytes and osteoblasts. This process is accentuated by corticosteroid-induced activation of osteoclasts, prolonged lifespan of osteoclasts, and immune-modulating effects. The resulting disruption of the osteocyte network and inhibition of repair processes in bone leads to a vicious cycle of ischaemia, cell death, trabecular disruption, fractures, and lack of repair, which ultimately results in bone collapse [9] . Various MRI-based staging systems have been proposed to identify different stages of ON, but all are limited in their ability to discriminate between reversible and progressive ON [1] [2] [3] 8] . Although marrow ischaemia is an early sign of ON [2, 18, 19] , it cannot be used to distinguish between bones that remain intact versus those that eventually progress to collapse. Other imaging studies describe direct and indirect imaging signs of fractures as sequela of advanced ON [5, 8, 18] . Unfortunately, by the time macroscopic epiphyseal fractures are already present, bone pain and impaired joint motion become clinically apparent [5, 8, 18] , and decompression procedures to save the joint are no longer possible. As early interventions are required to prevent joint destruction and long-term disabilities, we must identify patients with ON and risk for bone collapse before clinical symptoms are apparent [19] . BME is a common response to trauma [20] . It would, therefore, be rational to assume that BME might be the earliest sign of microfractures in ON, which poses a risk to bone collapse. Our finding is in accordance with a recent study performed in adult patients that showed a correlation of ONrelated BME with the presence of subchondral fractures and microfractures on histology [13] .
The location of ON within a bone is important, with epiphyseal lesions posing a risk to collapse while diaphyseal or metaphyseal osteonecrosis usually do not lead to biomechanical or clinical problems [11] . We, therefore, focused our investigations on epiphyseal ON. We also found in accordance with the literature that the femoral head and femoral condyles were the most common sites of steroid-induced osteonecrosis and that larger lesion size was associated with worse outcomes [11] . Accordingly, larger lesion size was correlated with the presence of BME. Surprisingly, we noticed that all ON of the proximal tibia in our study remained stable or improved on follow-up imaging with none progressing to collapse (0%), even though seven of these lesions were quite large, encompassing over 30% of the articular surface. While there have been several analyses of medial tibial plateau ON specifically, the natural evolution of these lesions has not been clearly defined [21] .
Of 11 tibial ON in our study, nine did not demonstrate BME on baseline imaging (82%), in keeping with our hypothesis that BME and eventual collapse are correlated. The lack of collapse of proximal tibial ON can be explained by differences in trabecular structure between the proximal and distal femur and the proximal tibia: The proximal tibia has a reported denser spongiosa and higher biomechanical strength [22] .
This study was limited due to its retrospective nature and lack of histopathological correlations of imaging findings.
However, to our knowledge, this is the first description of a predictive imaging biomarker of progressive ON in paediatric and adolescent leukaemia patients. Previous findings in adults [13, 23, 24 ] cannot be directly extrapolated to children because children have a higher regeneration potential. For example, while ON in adults usually does not resolve, ON in children can resolve completely [11] . Our study only included patients with epiphyseal osteonecrosis, because these are more prone to collapse. Future studies must evaluate if imagingbased classifications of epiphyseal and non-epiphyseal ON in multiple locations are more accurate for the clinical outcome [12] .
In summary, the presence of bone marrow oedema in the epiphysis of the proximal and distal femur on MRI studies predicts progression of osteonecrosis and results in bone collapse in paediatric and adolescent leukaemia patients. Bone marrow oedema may be the earliest sign of microfractures, even before subchondral fractures become apparent on imaging studies. Therefore, the finding of a BME could be used to stratify patients to joint preserving interventions and thereby, potentially prevent the need for total joint replacement. We evaluate this biomarker further in a prospective clinical trial. 
